Other Stories

AstraZeneca to hold additional global trial for its COVID-19 vaccine as questions mount Updated: 2020-11-27 13:16:09 KST

AstraZeneca appears to be planning an extra global trial for its COVID-19 vaccine to clear up uncertainty about the positive results of its current study..
The company's CEO said Thursday that the company wants the extra study to confirm the 90-percent efficacy rate that was shown in a portion of an existing trial.
An additional trial is not expected to hold up approvals in the U.K. or the EU.
Questions have been mounting after the company and its partner Oxford University, acknowledged that their trial results might've been affected by an error.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.